Role of T cells in type 2 diabetic nephropathy

Experimental Diabetes Research

Volumn 2011, Issue , 2011, Pages

  Wu, Chia Chao ^a,b   Sytwu, Huey Kang ^b   Lu, Kuo Cheng ^c   Lin, Yuh Feng ^a,d  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; MAMMALIAN TARGET OF RAPAMYCIN; NEUTRALIZING ANTIBODY; RAPAMYCIN;

CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG TARGETING; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; KIDNEY FAILURE; KIDNEY INJURY; LEUKOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; RISK FACTOR; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; BLOOD; CYTOLOGY; HYPERGLYCEMIA; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; KIDNEY; METABOLIC SYNDROME X; PATHOLOGY; PHYSIOLOGY;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; HUMANS; HYPERGLYCEMIA; INFLAMMATION; INSULIN RESISTANCE; KIDNEY; MACROPHAGES; METABOLIC SYNDROME X; T-LYMPHOCYTES; TH17 CELLS;

EID: 84555188233     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2011/514738     Document Type: Review

References (109)

1. Caramori M. L., Mauer M., Diabetes and nephropathy Current Opinion in Nephrology and Hypertension 2003 12 3 273 282 (Pubitemid 36578062)
2. Remuzzi G., Schieppati A., Ruggenenti P., Nephropathy in patients with type 2 diabetes The New England Journal of Medicine 2002 346 15 1145 1151 (Pubitemid 34984606)
3. Ritz E., Rychlik I., Locatelli F., Halimi S., End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions American Journal of Kidney Diseases 1999 34 5 795 808 (Pubitemid 29521694)
4. Wolf G., Ritz E., Diabetic nephropathy in type 2 diabetes prevention and patient management Journal of the American Society of Nephrology 2003 14 5 1396 1405 (Pubitemid 36514679)
5. Dronavalli S., Duka I., Bakris G. L., The pathogenesis of diabetic nephropathy Nature Clinical Practice Endocrinology Metabolism 2008 4 444 452
6. Cooper M. E., Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy Diabetologia 2001 44 11 1957 1972 (Pubitemid 33124041)
7. Gross J. L., de Azevedo M. J., Silveiro S. P., Canani L. H., Caramori M. L., Zelmanovitz T., Diabetic nephropathy: diagnosis, prevention, and treatment Diabetes Care 2005 28 1 164 176 (Pubitemid 40095801)
8. Wolf G., New insights into the pathophysiology of diabetic nephrophathy: from haemodynamics to molecular pathology European Journal of Clinical Investigation 2004 34 12 785 796 (Pubitemid 39657924)
9. Festa A., D'Agostino R. Jr., Howard G., Mykkanen L., Tracy R. P., Haffner S. M., Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS) Circulation 2000 102 1 42 47 (Pubitemid 30430551)
10. Frohlich M., Imhof A., Berg G., Association between C-reactive protein and features of the metabolic syndrome: a population-based study Diabetes Care 2000 23 12 1835 1839
11. Pickup J. C., Mattock M. B., Chusney G. D., Burt D., NIDDM as a disease of the innate immune system: association of acute- phase reactants and interleukin-6 with metabolic syndrome X Diabetologia 1997 40 11 1286 1292 (Pubitemid 27469668)
12. Navarro-Gonzalez J. F., Mora-Fernandez C., The role of inflammatory cytokines in diabetic nephropathy Journal of the American Society of Nephrology 2008 19 3 433 442 (Pubitemid 351355386)
13. Rivero A., Mora C., Muros M., Garcia J., Herrera H., Navarro-Gonzalez J. F., Pathogenic perspectives for the role of inflammation in diabetic nephropathy Clinical Science 2009 116 6 479 492
14. Brosius F. C. III, Alpers C. E., Bottinger E. P., Breyer M. D., Coffman T. M., Gurley S. B., Harris R. C., Kakoki M., Kretzler M., Leiter E. H., Levi M., McIndoe R. A., Sharma K., Smithies O., Susztak K., Takahashi N., Takahashi T., Mouse models of diabetic nephropathy Journal of the American Society of Nephrology 2009 20 12 2503 2512
15. Alpers C. E., Hudkins K. L., Mouse models of diabetic nephropathy Current Opinion in Nephrology and Hypertension 2011 20 3 278 284
16. Tesch G. H., Lim A. K., Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy American Journal of Physiology 2011 300 2 F301 F310
17. Abbas A. K., Murphy K. M., Sher A., Functional diversity of helper T lymphocytes Nature 1996 383 6603 787 793 (Pubitemid 26372655)
18. Mosmann T. R., Sad S., The expanding universe of T-cell subsets: Th1, Th2 and more Immunology Today 1996 17 3 138 146 (Pubitemid 26074503)
19. Miossec P., Korn T., Kuchroo V. K., Interleukin-17 and type 17 helper T cells The New England Journal of Medicine 2009 361 9 888 898
20. Shalev I., Schmelzle M., Robson S. C., Levy G., Making sense of regulatory T cell suppressive function. Seminars in Immunology. In press
21. van Belle T. L., Coppieters K. T., von Herrath M. G., Type 1 diabetes: etiology, immunology, and therapeutic strategies Physiological Reviews 2011 91 1 79 118
22. Heurtier A. H., Boitard C., T-cell regulation in murine and human autoimmune diabetes: the role of TH1 and TH2 cells Diabetes and Metabolism 1997 23 5 377 385 (Pubitemid 27502128)
23. Bending D., De La P. H., Veldhoen M., Phillips J. M., Uyttenhove C., Stockinger B., Cooke A., Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice Journal of Clinical Investigation 2009 119 3 565 572
24. Bradshaw E. M., Raddassi K., Elyaman W., Orban T., Gottlieb P. A., Kent S. C., Hafler D. A., Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells Journal of Immunology 2009 183 7 4432 4439
25. Honkanen J., Nieminen J. K., Gao R., Luopajarvi K., Salo H. M., Ilonen J., Knip M., Otonkoski T., Vaarala O., IL-17 immunity in human type 1 diabetes Journal of Immunology 2010 185 3 1959 1967
26. Nikolajczyk B. S., Jagannathan-Bogdan M, Shin H., Gyurko R, State of the union between metabolism and the immune system in type 2 diabetes Genes Immunity 2011 12 239 250
27. Hotamisligil G. S., Inflammation and metabolic disorders Nature 2006 444 7121 860 867 (Pubitemid 46024993)
28. Nishimura S., Manabe I., Nagasaki M., Seo K., Yamashita H., Hosoya Y., Ohsugi M., Tobe K., Kadowaki T., Nagai R., Sugiura S., In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue Journal of Clinical Investigation 2008 118 2 710 721 (Pubitemid 351206559)
29. Xu H., Barnes G. T., Yang Q., Tan G., Yang D., Chou C. J., Sole J., Nichols A., Ross J. S., Tartaglia L. A., Chen H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance Journal of Clinical Investigation 2003 112 12 1821 1830 (Pubitemid 38063705)
30. Wu H., Ghosh S., Perrard X. D., Feng L., Garcia G. E., Perrard J. L., Sweeney J. F., Peterson L. E., Chan L., Smith C. W., Ballantyne C. M., T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity Circulation 2007 115 8 1029 1038 (Pubitemid 46328297)
31. Rausch M. E., Weisberg S., Vardhana P., Tortoriello D. V., Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration International Journal of Obesity 2008 32 3 451 463 (Pubitemid 351414814)
32. Kintscher U., Hartge M., Hess K., Foryst-Ludwig A., Clemenz M., Wabitsch M., Fischer-Posovszky P., Barth T. F., Dragun D., Skurk T., Hauner H., Blher M., Unger T., Wolf A.-M., Knippschild U., Hombach V., Marx N., T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 7 1304 1310
33. Monney L., Sabatos C. A., Gaglia J. L., Ryu A., Waldner H., Chernova T., Manning S., Greenfield E. A., Coyle A. J., Sobel R. A., Freeman G. J., Kuchroo V. K., Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease Nature 2002 415 536 541 (Pubitemid 34130609)
34. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., Otsu M., Hara K., Ueki K., Sugiura S., Yoshimura K., Kadowaki T., Nagai R., CD8 + effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity Nature Medicine 2009 15 8 914 920
35. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., Dorfman R., Wang Y., Zielenski J., Mastronardi F., Maezawa Y., Drucker D. J., Engleman E., Winer D., Dosch H. M., Normalization of obesity-associated insulin resistance through immunotherapy Nature Medicine 2009 15 8 921 929
36. Leipe J., Skapenko A., Lipsky P. E., Schulze-Koops H., Regulatory T cells in rheumatoid arthritis Arthritis Research and Therapy 2005 7 3 93 99 (Pubitemid 40775169)
37. Wen Y., Gu J., Li S. L., Reddy M. A., Natarajan R., Nadler J. L., Elevated glucose and diabetes promote interleukin-12 cytokine gene expression in mouse macrophages Endocrinology 2006 147 5 2518 2525
38. Ha H., Yu M. R., Choi Y. J., Kitamura M., Lee H. B., Role of high glucose-induced nuclear factor- B activation in monocyte chemoattractant protein-1 expression by mesangial cells Journal of the American Society of Nephrology 2002 13 4 894 902 (Pubitemid 34274085)
39. Chen J. S., Lee H. S., Jin J. S., Chen A., Lin S. H., Ka S. M., Lin Y. F., Attenuation of mouse mesangial cell contractility by high glucose and mannitol: involvement of protein kinase C and focal adhesion kinase Journal of Biomedical Science 2004 11 2 142 151 (Pubitemid 38269804)
40. Bending J. J., Lobo-Yeo A., Vergani D., Biberti G., Proteinuria and activated T-lymphocytes in diabetic nephropathy Diabetes 1988 37 5 507 511
41. Castano L., Eisenbarth G. S., Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat Annual Review of Immunology 1990 8 647 679 (Pubitemid 20135642)
42. Galkina E., Ley K., Leukocyte recruitment and vascular injury in diabetic nephropathy Journal of the American Society of Nephrology 2006 17 2 368 377
43. Chow F., Ozols E., Nikolic-Paterson D. J., Atkins R. C., Tesch G. H., Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury Kidney International 2004 65 1 116 128 (Pubitemid 38037496)
44. Segerer S., Nelson P. J., Schlondorff D., Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies Journal of the American Society of Nephrology 2000 11 1 152 176 (Pubitemid 30020438)
45. Bohlender J. M., Franke S., Stein G., Wolf G., Advanced glycation end products and the kidney American Journal of Physiology 2005 289 4 F645 F659
46. Goh S. Y., Cooper M. E., The role of advanced glycation end products in progression and complications of diabetes Journal of Clinical Endocrinology and Metabolism 2008 93 4 1143 1152 (Pubitemid 351519698)
47. Imani F., Horii Y., Suthanthiran M., Skolnik E. Y., Makita Z., Sharma V., Sehajpal P., Vlassara H., Advanced glycosylation endproduct-specific receptors on human and rat T- lymphocytes mediate synthesis of interferon : role in tissue remodeling Journal of Experimental Medicine 1993 178 6 2165 2172 (Pubitemid 23344874)
48. Navarro-Gonzalez J. F., Mora-Fernandez C., de Fuentes M. M., Garcia-Perez J., Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy Nature Reviews Nephrology 2011 7 6 327 340
49. Tesch G. H., Macrophages and diabetic nephropathy Seminars in Nephrology 2010 30 3 290 301
50. Wang Y., Harris D. C., Macrophages in renal disease Journal of the American Society of Nephrology 2011 22 1 21 27
51. Moriya R., Manivel J. C., Mauer M., Juxtaglomerular apparatus T-cell infiltration affects glomerular structure in Type 1 diabetic patients Diabetologia 2004 47 1 82 88 (Pubitemid 38141943)
52. Chung A. C., Lan H. Y., Chemokines in renal injury Journal of the American Society of Nephrology 2011 22 5 802 809
53. Chow F. Y., Nikolic-Paterson D. J., Ozols E., Atkins R. C., Tesch G. H., Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice Journal of the American Society of Nephrology 2005 16 6 1711 1722 (Pubitemid 41716477)
54. Sugimoto H., Shikata K., Hirata K., Akiyama K., Matsuda M., Kushiro M., Shikata Y., Miyatake N., Miyasaka M., Makino H., Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation Diabetes 1997 46 12 2075 2081 (Pubitemid 27512099)
55. Matsui H., Suzuki M., Tsukuda R., Iida K., Miyasaka M., Ikeda H., Expression of ICAM-1 on glomeruli is associated with progression of diabetic nephropathy in a genetically obese diabetic rat, Wistar fatty Diabetes Research and Clinical Practice 1996 32 1-2 1 9 (Pubitemid 26191380)
56. Coimbra T. M., Janssen U., Grone H. J., Ostendorf T., Kunter U., Schmidt H., Brabant G., Floege J., Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes Kidney International 2000 57 1 167 182 (Pubitemid 30227764)
57. Navarro J. F., Mora-Fernandez C., The role of TNF- in diabetic nephropathy: pathogenic and therapeutic implications Cytokine and Growth Factor Reviews 2006 17 6 441 450 (Pubitemid 44803222)
58. Banba N., Nakamura T., Matsumura M., Kuroda H., Hattori Y., Kasai K., Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy Kidney International 2000 58 2 684 690 (Pubitemid 30620017)
59. Moore K. J., Wada T., Barbee S. D., Kelley V. R., Gene transfer of RANTES elicits autoimmune renal injury in MRL-Fas(lpr) mice Kidney International 1998 53 6 1631 1641 (Pubitemid 28243746)
60. Wong C. K., Ho A. W., Tong P. C., Yeung C. Y., Chan J. C., Kong A. P., Lam C. W., Aberrant expression of soluble co-stimulatory molecules and adhesion molecules in type 2 diabetic patients with nephropathy Journal of Clinical Immunology 2008 28 1 36 43
61. Lee F. T., Cao Z., Long D. M., Panagiotopoulos S., Jerums G., Cooper M. E., Forbes J. M., Interactions between angiotensin II and NF- B-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy Journal of the American Society of Nephrology 2004 15 8 2139 2151 (Pubitemid 39031352)
62. Mezzano S., Droguett A., Burgos M. E., Ardiles L. G., Flores C. A., Aros C. A., Caorsi I., Ruiz-Ortega M., Egido J., Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy Kidney International 2003 64 86, supplement S64 S70
63. Kanetsuna Y., Takahashi K., Nagata M., Gannon M. A., Breyer M. D., Harris R. C., Takahashi T., Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice American Journal of Pathology 2007 170 5 1473 1484 (Pubitemid 47339294)
64. Chow F. Y., Nikolic-Paterson D. J., Ozols E., Atkins R. C., Rollin B. J., Tesch G. H., Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice Kidney International 2006 69 1 73 80 (Pubitemid 43117741)
65. Satriano J. A., Hora K., Shan Z., Stanley E. R., Mori T., Schlondorff D., Regulation of monocyte chemoattractant protein-1 and macrophage colony- stimulating factor-1 by IFN-, tumor necrosis factor-, IgG aggregates, and cAMP in mouse mesangial cells Journal of Immunology 1993 150 5 1971 1978 (Pubitemid 23129675)
66. Mora C., Navarro J. F., Inflammation and pathogenesis of diabetic nephropathy Metabolism 2004 53 2 265 267
67. Mora C., Navarro J. F., Inflammation and diabetic nephropathy Current Diabetes Reports 2006 6 6 463 468 (Pubitemid 44896406)
68. Navarro J. F., Mora C., Role of inflammation in diabetic complications Nephrology Dialysis Transplantation 2005 20 12 2601 2604 (Pubitemid 41672253)
69. Han S. Y., So G. A., Jee Y. H., Han K. H., Kang Y. S., Kim H. K., Kang S. W., Han D. S., Han J. Y., Cha D. R., Effect of retinoic acid in experimental diabetic nephropathy Immunology and Cell Biology 2004 82 6 568 576
70. Huber T. B., Reinhardt H. C., Exner M., Burger J. A., Kerjaschki D., Saleem M. A., Pavenst#xe4;dt H., Expression of functional CCR and CXCR chemokine receptors in podocytes Journal of Immunology 2002 168 12 6244 6252 (Pubitemid 34620044)
71. Hohenstein B., Daniel C., Hausknecht B., Boehmer K., Riess R., Amann K. U., Hugo C. P. M., Correlation of enhanced thrombospondin-1 expression, TGF- signalling and proteinuria in human type-2 diabetic nephropathy Nephrology Dialysis Transplantation 2008 23 12 3880 3887
72. Korpinen E., Groop P. H., Fagerudd J. A., Teppo A. M., Akerblom H. K., Vaarala O., Increased secretion of TGF- 1 by peripheral blood mononuclear cells from patients with type 1 diabetes mellitus with diabetic nephropathy Diabetic Medicine 2001 18 2 121 125 (Pubitemid 32238957)
73. Vesey D. A., Cheung C., Cuttle L., Endre Z., Gobe G., Johnson D. W., Interleukin-1 stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor- -dependent mechanism Journal of Laboratory and Clinical Medicine 2002 140 5 342 350 (Pubitemid 35302027)
74. Lim A. K., Nikolic-Paterson D. J., Ma F. Y., Ozols E., Thomas M. C., Flavell R. A., Davis R. J., Tesch G. H., Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice Diabetologia 2009 52 2 347 358
75. Endemann D. H., Schiffrin E. L., Endothelial dysfunction Journal of the American Society of Nephrology 2004 15 8 1983 1992 (Pubitemid 39031337)
76. Stehouwer C. D., Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease Nephrology Dialysis Transplantation 2004 19 4 778 781 (Pubitemid 38455645)
77. Schena F. P., Gesualdo L., Pathogenetic mechanisms of diabetic nephropathy Journal of the American Society of Nephrology 2005 16 3, supplement 1 S30 S33
78. Yamagishi S. I., Fukami K., Ueda S., Okuda S., Molecular mechanisms of diabetic nephropathy and its therapeutic intervention Current Drug Targets 2007 8 8 952 959
79. Odobasic D., Kitching A. R., Tipping P. G., Holdsworth S. R., CD80 and CD86 costimulatory molecules regulate crescentic glomerulonephritis by different mechanisms Kidney International 2005 68 2 584 594 (Pubitemid 43323113)
80. Wu C. C., Chen J. S., Lu K. C., Chen C. C., Lin S. H., Chu P., Sytwu H. K., Lin Y. F., Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy Clinica Chimica Acta 2010 411 9-10 700 704
81. Bugawan T. L., Mirel D. B., Valdes A. M., Panelo A., Pozzilli P., Erlich H. A., Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among filipinos American Journal of Human Genetics 2003 72 6 1505 1514 (Pubitemid 36628389)
82. Mittal R. D., Manchanda P. K., Association of interleukin (IL)-4 intron-3 and IL-6 -174 G/C gene polymorphism with susceptibility to end-stage renal disease Immunogenetics 2007 59 2 159 165 (Pubitemid 46130794)
83. Lalani I., Bhol K., Ahmed A. R., Interleukin-10: biology, role in inflammation and autoimmunity Annals of Allergy, Asthma and Immunology 1997 79 6 469 484 (Pubitemid 28041808)
84. van Exel E., Gussekloo J., de Craen A. J., Frolich M., Bootsma-Van Der W. A., Westendorp R. G., Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-plus study Diabetes 2002 51 4 1088 1092 (Pubitemid 34438354)
85. Mysliwska J., Zorena K., Semetkowska-Jurkiewicz E., Rachon D., Suchanek H., Mysliwski A., High levels of circulating interleukin-10 in diabetic nephropathy patients European Cytokine Network 2005 16 2 117 122 (Pubitemid 46646220)
86. Wong C. K., Ho A. W., Tong P. C., Yeung C. Y., Kong A. P., Lun S. W., Chan J. C., Lam C. W., Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy Clinical and Experimental Immunology 2007 149 1 123 131 (Pubitemid 46897099)
87. Zamauskaite A., Yaqoob M. M., Madrigal J. A., Cohen S. B., The frequency of Th2 type cells increases with time on peritoneal dialysis in patients with diabetic nephropathy European Cytokine Network 1999 10 2 219 226 (Pubitemid 29332778)
88. Mtiraoui N., Ezzidi I., Kacem M., Mohamed M. B. H., Chaieb M., Jilani A. B. H., Mahjoub T., Almawi W. Y., Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients Diabetes/Metabolism Research and Reviews 2009 25 1 57 63
89. Ezzidi I., Mtiraoui N., Kacem M., Mallat S. G., Mohamed M. B. H., Chaieb M., Mahjoub T., Almawi W. Y., Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients Clinical Endocrinology 2009 70 3 401 407
90. Jagannathan-Bogdan M., McDonnell M. E., Shin H., Rehman Q., Hasturk H., Apovian C. M., Nikolajczyk B. S., Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes Journal of Immunology 2011 186 2 1162 1172
91. Arababadi M. K., Nosratabadi R., Hassanshahi G., Yaghini N., Pooladvand V., Shamsizadeh A., Hakimi H., Derakhshan R., Nephropathic complication of type-2 diabetes is following pattern of autoimmune diseases? Diabetes Research and Clinical Practice 2010 87 1 33 37
92. Xu J., Su H. L., Wang J. H., Zhang C. H., Role of CD4+CD25+Foxp3+ regulatory T cells in type 2 diabetic nephropathy Journal of Southern Medical University 2009 29 1 137 139
93. Xiao X., Ma B., Dong B., Zhao P., Tai N., Chen L., Susan Wong F., Wen L., Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice Journal of Autoimmunity 2009 32 2 85 93
94. Lim A. K. H., Ma F. Y., Nikolic-Paterson D. J., Kitching A. R., Thomas M. C., Tesch G. H., Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury Diabetologia 2010 53 8 1772 1782
95. Nguyen D., Ping F., Mu W., Hill P., Atkins R. C., Chadban S. J., Macrophage accumulation in human progressive diabetic nephropathy Nephrology 2006 11 3 226 231 (Pubitemid 43829442)
96. Tesch G. H., Role of macrophages in complications of Type 2 diabetes Clinical and Experimental Pharmacology and Physiology 2007 34 10 1016 1019 (Pubitemid 47274561)
97. Meyer T. W., Immunosuppression for diabetic glomerular disease? Kidney International 2003 63 1 377 378 (Pubitemid 35463944)
98. Gao Q., Shen W., Qin W., Zheng C., Zhang M., Zeng C., Wang S., Wang J., Zhu X., Liu Z., Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy Nephrology, Dialysis, Transplantation 2010 25 11 3539 3547
99. Hagiwara S., Makita Y., Gu L., Tanimoto M., Zhang M., Nakamura S., Kaneko S., Itoh T., Gohda T., Horikoshi S., Tomino Y., Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation Nephrology Dialysis Transplantation 2006 21 3 605 615 (Pubitemid 43372905)
100. Inoki K., Role of TSC-mTOR pathway in diabetic nephropathy Diabetes Research and Clinical Practice 2008 82 supplement 1 S59 S62
101. Lieberthal W., Levine J. S., The role of the mammalian target of rapamycin (mTOR) in renal disease Journal of the American Society of Nephrology 2009 20 12 2493 2502
102. Mori H., Inoki K., Masutani K., Wakabayashi Y., Komai K., Nakagawa R., Guan K. -L., Yoshimura A., The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential Biochemical and Biophysical Research Communications 2009 384 4 471 475
103. Sakaguchi M., Isono M., Isshiki K., Sugimoto T., Koya D., Kashiwagi A., Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice Biochemical and Biophysical Research Communications 2006 340 1 296 301 (Pubitemid 41827680)
104. Lloberas N., Cruzado J. M., Franquesa M., Herrero-Fresneda I., Torras J., Alperovich G., Rama I., Vidal A., Griny J. M., Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats Journal of the American Society of Nephrology 2006 17 5 1395 1404 (Pubitemid 43673420)
105. Yang Y., Wang J., Qin L., Shou Z., Zhao J., Wang H., Chen Y., Chen J., Rapamycin prevents early steps of the development of diabetic nephropathy in rats American Journal of Nephrology 2007 27 5 495 502 (Pubitemid 47482007)
106. Turgut F., Bolton W. K., Potential new therapeutic agents for diabetic kidney disease American Journal of Kidney Diseases 2010 55 5 928 940
107. Dagenais N. J., Jamali F., Protective effects of angiotensin II interruption: evidence for antiinflammatory actions Pharmacotherapy 2005 25 9 1213 1229 (Pubitemid 41244813)
108. Han S. Y., Kim C. H., Kim H. S., Jee Y. H., Song H. K., Lee M. H., Han K. H., Kim H. K., Kang Y. S., Han J. Y., Kim Y. S., Cha D. R., Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats Journal of the American Society of Nephrology 2006 17 5 1362 1372
109. Utimura R., Fujihara C. K., Mattar A. L., Malheiros D. M., Noronha I. L., Zatz R., Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes Kidney International 2003 63 1 209 216 (Pubitemid 35463923)